ARCHIVES

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

This article is from The Cancer Letter archive.

Vol. 31 No. 18 | May 6, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Li, Gart Retire Forom NCI; Clifford Heads Diet Branch; ASTRO Meeting Nov. 4-8 In Washington

October 18, 1991

ACS Prostate Cancer Screening Guideline Urges Doctor-Patient Informed Decision

March 5, 2010

NCAB Delays Approval Of New Comprehensive Center Guidelines

October 12, 1979

NCI Bypass Budget An Underutilized Document and Ignored By MB; Deserves Attention Of Congress

January 20, 1989

In Brief: Nobel Prize Awarded to Blobel for Research On Protein Signaling; Work Funded By NIH

October 15, 1999

Common Chemotherapy Fertilizes Marrow Before Tumors Take Root

May 25, 2012